Boiron (FRA:BON) Other Current Payables : €2.7 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Boiron Other Current Payables?

Boiron's Other Current Payables for the quarter that ended in Dec. 2023 was €2.7 Mil.

Boiron's quarterly Other Current Payables increased from Dec. 2022 (€3.2 Mil) to Jun. 2023 (€3.7 Mil) but then declined from Jun. 2023 (€3.7 Mil) to Dec. 2023 (€2.7 Mil).

Boiron's annual Other Current Payables declined from Dec. 2021 (€4.9 Mil) to Dec. 2022 (€3.2 Mil) and declined from Dec. 2022 (€3.2 Mil) to Dec. 2023 (€2.7 Mil).

Boiron Other Current Payables Historical Data

The historical data trend for Boiron's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Other Current Payables Chart

Boiron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

6.47

4.22

4.85

3.22

2.68

Boiron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial															4.85	2.58	3.22	3.71	2.68

Boiron Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Boiron Other Current Payables Related Terms

Thank you for viewing the detailed overview of Boiron's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (FRA:BON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

BOIRF:USA BOI:France BON:Germany

Address

2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510

Website

http://www.boiron.com

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.